Genmab A (GMAB) Current Assets (2023 - 2025)

Genmab A's Current Assets history spans 3 years, with the latest figure at $2.9 billion for Q4 2025.

  • For Q4 2025, Current Assets fell 26.03% year-over-year to $2.9 billion; the TTM value through Dec 2025 reached $2.9 billion, down 26.03%, while the annual FY2025 figure was $2.9 billion, 26.03% down from the prior year.
  • Current Assets reached $2.9 billion in Q4 2025 per GMAB's latest filing, down from $3.9 billion in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $4.9 billion in Q4 2023 to a low of $2.9 billion in Q4 2025.
  • Average Current Assets over 3 years is $3.9 billion, with a median of $3.9 billion recorded in 2024.
  • Peak YoY movement for Current Assets: dropped 20.6% in 2024, then decreased 26.03% in 2025.
  • A 3-year view of Current Assets shows it stood at $4.9 billion in 2023, then decreased by 20.6% to $3.9 billion in 2024, then fell by 26.03% to $2.9 billion in 2025.
  • Per Business Quant, the three most recent readings for GMAB's Current Assets are $2.9 billion (Q4 2025), $3.9 billion (Q4 2024), and $4.9 billion (Q4 2023).